Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Skin cancer

SHTAC research projects are listed according to topic area.

Click on a topic area listed below to view associated publications. 

 

Kalita N, Lord J, Colquitt J, Loveman E, Scott DA, Frampton G. Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma: A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2019.

Cooper K, Harris P, Frampton G, Boehler C, Shepherd J. Cobimetinib in combination with vemurafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma: A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2016.

Cooper K, Kalita N, Streit E, Shepherd J, Chorozoglou M, Frampton G. Nivolumab for treating advanced (unresectable or metastatic) melanoma: A Single Technology Appraisal. Southampton Health Technology Assessments Centre (SHTAC), 2015.

Privacy Settings